Press Releases about Xenon Pharmaceuticals Inc
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024
January 08, 2024
Via GlobeNewswire
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://www.marketbeat.com/logos/articles/med_20231228125224_bristol-myers-squibbs-big-buys-18.jpg)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Xenon Pharmaceuticals Announces Proposed Public Offering
November 29, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.